The diagnostic role of salivary gland fine-needle aspiration (SG-FNA) is well established in the preoperative evaluation of patients with salivary gland lesions. At present, most salivary SG-FNA specimens are diagnosed based on conventional diagnostic criteria. However, there exists a lack of uniform reporting for these specimens to guide the clinical management of patients. This void motivated a group of experienced cytopathologists to spearhead the development of a uniform reporting system. This international panel, under the sponsorship of the American Society of Cytopathology (ASC) and the International Academy of Cytology (IAC), gathered in September 2015 at the European Congress of Cytology, held in Milan, Italy, to propose the “Milan System for Reporting Salivary Gland Cytopathology” (MSRSGC). This effort sparked the interest of many and brought forth an agreement to develop an evidence-based tiered classification consisting of 6 diagnostic categories. It is hoped that this standard reporting system will enhance the overall effectiveness of SG-FNA reporting across institutions, with the ultimate result being better communication and improved patient care.

1.
Schmidt RL, Hall BJ, Layfield LJ: A systematic review and meta-analysis of the diagnostic accuracy of ultrasound-guided core needle biopsy for salivary gland lesions. Am J Clin Pathol 2011; 136: 516–526.
2.
Ahn S, Kim Y, Oh YL: Fine needle aspiration cytology of benign salivary gland tumors with myoepithelial cell participation: an institutional experience of 575 cases. Acta Cytol 2013; 57: 567–574.
3.
Tyagi R, Dey P: Diagnostic problems of salivary gland tumors. Diagn Cytopathol 2015; 43: 495–509.
4.
Schmidt RL, Narra KK, Witt BL, Factor RE: Diagnostic accuracy studies of fine-needle aspiration show wide variation in reporting of study population characteristics: implications for external validity. Arch Pathol Lab Med 2014; 138: 88–97.
5.
Liu CC, Jethwa AR, Khariwala SS, Johnson J, Shin JJ: Sensitivity, specificity, and posttest probability of parotid fine needle aspiration: a systematic review and meta-analysis. Otolaryngol Head Neck Surg 2016; 154: 9–23.
6.
Griffith CC, Pai RK, Schneider F, Duvvuri U, Ferris RL, Johnson JT, Seethala RR: Salivary gland tumor fine-needle aspiration cytology: a proposal for a risk stratification classification. Am J Clin Pathol 2015; 143: 839–853.
7.
Wang H, Fundakowski C, Khurana JS, Jhala N: Fine-needle aspiration biopsy of salivary gland lesions. Arch Pathol Lab Med 2015; 139: 1491–1497.
8.
Rossi ED, Wong LQ, Bizzarro T, Petrone G, Mule A, Fadda G, Baloch ZW: The impact of FNAC in the management of salivary gland lesions: institutional experiences leading to a risk-based classification scheme. Cancer Cytopathol 2016; 124: 388–396.
9.
Wei S, Layfield LJ, LiVolsi VA, Montone KT, Baloch ZW: Reporting of fine needle aspiration (FNA) specimens of salivary gland lesions: a comprehensive review. Diagn Cytopathol 2017; 45: 820–827.
10.
Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, Vielh P, Kurtycz DFI: The Milan System for Reporting Salivary Gland Cytopathology: analysis and suggestions of initial survey. Cancer 2017; 125: 757–766.
11.
Faquin W, Rossi ED: “The Milan System for reporting salivary gland Cytopathology”. ASC Bull JASC 2017; 6: 1–3.
12.
Colella G, Cannavale R, Flamminio F, Foschini MP: Fine-needle aspiration cytology of salivary gland lesions: a systematic review. J Oral Maxillofac Surg 2010; 68: 2146–2153.
13.
Hughes JH, Volk EE, Wilbur DC; Cytopathology Resource Committee of the College of American Pathologists: Pitfalls in salivary gland fine-needle aspiration cytology: lessons from the College of American Pathologists Interlaboratory Comparison Program in Nongynecologic Cytology. Arch Pathol Lab Med 2005; 129: 26–31.
14.
Song IH, Song JS, Sung CO, Roh JL, Choi SH, Nam SY, et al: Accuracy of core needle biopsy versus fine needle aspiration cytology for diagnosing salivary gland tumors. J Pathol Transl Med 2015; 49: 136–143.
15.
Maleki Z, Miller JA, Arab SE, Fadda G, Bo P, Wise O, Rossi ED, Jhala N, Ashish C, Ali SZ, Wang H: “Suspicious” salivary gland FNA: risk of malignancy and interinstitutional variability. Cancer 2018; 126: 94–100.
16.
Pusztaszeri M, Faquin WC: Update in salivary gland cytopathology: recent molecular advances and diagnostic applications. Semin Diagn Pathol 2014; 2570: 115–121.
17.
Pusztaszeri M, Shadow P, Ushiku A, Bordignon P, McKee TA, Faquin WC: MYB immunostaining is a useful ancillary test for distinguishing adenoid cystic carcinoma from pleomorphic adenoma in fine-needle aspiration biopsy specimens. Cancer Cytopathol 2014; 122: 257–265.
18.
Griffith CC, Schmitt AC, Little JL, Magliocca KR: New developments in salivary gland pathology: clinically useful ancillary testing and new potentially targetable molecular alterations. Arch Pathol Lab Med 2017; 141: 381–395.
19.
Foo WC, Jo VY, Krane JF: Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms. Cancer Cytopathol 2016; 124: 397–405.
20.
Jo VY, Sholl LM, Krane JF: Distinctive patterns of CTNNB1 (β-catenin) alterations in salivary gland basal cell adenoma and basal cell adenocarcinoma. Am J Surg Pathol 2016; 40: 1143–1150.
21.
Baloch ZW, Faquin WC, Layfield LJ: Is it time to develop a tiered classification scheme for salivary gland fine-needle aspiration specimens? Diagn Cytopathol 2017; 45: 285–286.
22.
Bajwa MS, Mitchell DA, Brennan PA: Is it time we adopted a classification for parotid gland cytology? Br J Oral Maxillofac Surg 2014; 52: 99–101.
23.
Bajwa MS, Rose SJ, Mairembam P, Nash R, Hotchen D, Godden D, Alam P, Daborn L, Spedding AV, Brennan PA: Feasibility of a novel classification for parotid gland cytology: a retrospective review of 512 cytology reports taken from 4 United Kingdom general hospitals. Head Neck 2016; 38: 1596–1603.
24.
Nayar R, Wilbur DC: The Pap test and Bethesda 2014. Cancer Cytopath 2015; 125: 271–81.
25.
Cibas ES, Ali SZ: The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria and Explanatory Notes, ed 2. Berlin, Springer, 2017.
26.
Rosenthal D, Wojcik EM, Kurtycz DFI: The Paris System for Reporting Urinary Cytology, ed 1. Berlin, Springer, 2016.
27.
Bishop Pitman M, Layfield LJ: The Papanicolaou Society of Cytopathology System for Reporting Pancreaticobiliary Cytology: Definitions, Criteria and Explanatory Notes, ed 1. Berlin, Springer, 2015.
28.
Wang H, Malik A, Maleki Z, Rossi ED, Ping B, Chandra A, Ali SZ, Fadda G, Wang J, Arab SE, Zhao H, Jhala N: “Atypical” salivary gland fine needle aspiration: risk of malignancy and interinstitutional variability. Diagn Cytopathol 2017; 45: 1088–1094.
29.
Rohilla M, Singh P, Rajwanshi A, Gupta N, Srinivasan R, Dey P, Vashishta RK: Three-year cytohistological correlation of salivary gland FNA cytology at a tertiary center with the application of the Milan system for risk stratification. Cancer Cytopathol 2017; 125: 767–775.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.